Oribel Capital Management’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
2021
Q3
$2.1M Hold
2021
Q2
$2.08M Sell
2021
Q1
$2.05M Buy